Condition
ACE Inhibitor
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Terminated1
Not Yet Recruiting1
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07197372Not Yet Recruiting
Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy
NCT03991910Phase 3Unknown
The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients
NCT00338091Not ApplicableTerminated
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
Showing all 3 trials